(7) Contraindications: active gastrointestinal ulcer/bleeding patients, or recurrent ulcers/bleeding patients.<BR>(8) Drug analysis: dichlorofennate sodium slow release tablets can promote the combination of peanut tetraoleic acid and triglycerides, reduce the concentration of free peanut tetraoleic acid in cells, indirectly inhibit the synthesis of white triene. It is a nonsteroidal anti-inflammatory drug, which has a stronger inhibitory effect on prostaglandin synthesis than oral dichlorofentanrate sodium reprieves aspirin and anti-inflammatory pain. Used to reduce postoperative pain and inflammation.
正在翻译中..